In all groups, except for individuals with reduced quality of life in the OSA group and those with pronounced insomnia symptoms in the CG, morning SERT levels were higher than evening levels (all p < 0.05; Table 2). The gene discussed is SLC6A4; the disease is insomnia measurement.